Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-11-25, Stock:NVS, The news for the past five days is as follows:
2019-11-18: NEWS1: How Technology Will Disrupt the Way Companies Innovate.NEWS2: UPDATE 1-Novartis switches gears in Shanghai from research to drug development.NEWS3: Novartis Receives FDA Nod for Adakveo in Sickle Cell Disease.NEWS4: Novartis shifts Shanghai's focus from research to early development.NEWS5: Jazz's (JAZZ) Sleep Drug Sunosi Nears Approval in Europe.NEWS6: Novartis shifts Shanghai's focus from research to early development.NEWS7: Medtech firm Biofourmis doubles valuation with acquisition, Novartis deal.
2019-11-19: NEWS1: The Medicines Company Stock Is Soaring Because Novartis Might Want to Buy It.NEWS2: Medicines Co. Is Said to Attract Suitors Including Novartis.NEWS3: Merck's Heart Failure Candidate Meets Goal in Phase III Study.NEWS4: Aerie to Acquire Dry Eye Disease-Focused Pharma Avizorex.NEWS5: UPDATE 1-Novartis eyes Medicines Co to boost cardio franchise - report.NEWS6: Why Vanguard’s chief economist says there is an elevated risk of a ‘large drawdown’ in stocks.NEWS7: Medicines Co. shares jump 17% in premarket after report of potential Novartis offer.NEWS8: Novartis declines comment on reported interest in Medicines Co.NEWS9: [video]Medicines Co. Surges After Cholesterol Drug Maker Linked to Novartis Takeover.NEWS10: Home Depot, Kohl's, Boeing, Salesforce, Medicines Co. - 5 Things You Must Know.NEWS11: Medicines Co. Surges After Cholesterol Drug Maker Linked to Novartis Takeover.
2019-11-20: NEWS1: Charity to pay $4 million to resolve U.S. pharma kickback probe.NEWS2: Charity to pay $4 million to resolve U.S. pharma kickback probe.NEWS3: Charity to pay $4 million to resolve U.S. pharma kickback probe.NEWS4: Novartis Is Moving Higher on the Charts, Go Long or Add to Longs.NEWS5: Medicines Company Up on Rumors of Potential Buyout by Novartis.NEWS6: Keytruda researcher launches cancer-focused Werewolf Therapeutics with $56M.
2019-11-21: NEWS1: Biogen, Novartis named in settlement between foundation, federal prosecutors.NEWS2: The Medicines Company Soars Amid Acquisition Whispers.NEWS3: ISS Global A/S -- Moody's changes outlook on ISS's Baa2 ratings to negative from stable.
2019-11-22: NEWS1: Pfizer Is the Dow’s Worst Stock. A New Strategy Makes It Worth Another Look..NEWS2: Pharma Stock Roundup: FDA Nod to NVS' & AZN's Drugs, BMY-CELG Merger Closes.

Answer: Rise